BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05821088-completion@plaintrial.com
DTSTAMP:20261027T213827Z
DTSTART;VALUE=DATE:20261231
SUMMARY:Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Sal
 vage Therapy for Transplant Eligible Patients With Relapsed/ Refractory La
 rge B-Cell Lymphoma — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05821088
URL:https://plaintrial.com/trial/NCT05821088
END:VEVENT
END:VCALENDAR
